Brokerages forecast that Field Trip Health Ltd. (NASDAQ:FTRP – Get Rating) will announce earnings of ($0.18) per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Field Trip Health’s earnings. The highest EPS estimate is ($0.14) and the lowest is ($0.20). The company is expected to issue its next quarterly earnings report on Monday, January 1st.
According to Zacks, analysts expect that Field Trip Health will report full-year earnings of ($0.72) per share for the current year, with EPS estimates ranging from ($0.76) to ($0.70). For the next year, analysts anticipate that the business will report earnings of ($0.74) per share, with EPS estimates ranging from ($0.95) to ($0.42). Zacks’ earnings per share averages are an average based on a survey of research analysts that cover Field Trip Health.
Field Trip Health (NASDAQ:FTRP – Get Rating) last announced its quarterly earnings results on Tuesday, February 15th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.02). The business had revenue of $1.09 million during the quarter, compared to the consensus estimate of $1.35 million.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Scotia Capital Inc. acquired a new stake in Field Trip Health during the 3rd quarter worth about $219,000. Verition Fund Management LLC acquired a new stake in Field Trip Health in the 3rd quarter worth about $822,000. Point72 Asset Management L.P. acquired a new stake in Field Trip Health in the 3rd quarter worth about $4,515,000. Citadel Advisors LLC boosted its holdings in Field Trip Health by 296.2% in the 4th quarter. Citadel Advisors LLC now owns 47,252 shares of the company’s stock worth $117,000 after buying an additional 35,326 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in Field Trip Health in the 4th quarter worth about $61,000. 16.84% of the stock is owned by hedge funds and other institutional investors.
FTRP stock opened at $0.77 on Wednesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 9.41 and a current ratio of 9.41. Field Trip Health has a 12-month low of $0.71 and a 12-month high of $6.74. The business has a 50-day moving average price of $1.25.
Field Trip Health Company Profile (Get Rating)
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules.
- Get a free copy of the StockNews.com research report on Field Trip Health (FTRP)
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- The Low In Lordstown Motors May Not Be The Last
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with MarketBeat.com's FREE daily email newsletter.